ePrivacy and GPDR Cookie Consent by Cookie Consent

Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program


Nov. 12, 2019


Retrospective data suggest mutations in DNA damage response genes predict better overall survival with platinum chemotherapy. Genes include BRCA1/2, PALB2, ATM, ATR, BAP1, CHEK1/2, RAD & FANC family and others; germline or somatic.